POLYMED

Poly Medicure Share Price

₹2,527.75 +24.3 (0.97%)

28 Dec, 2024 00:39

SIP TrendupStart SIP in POLYMED

Start SIP

Performance

  • Low
  • ₹2,482
  • High
  • ₹2,594
  • 52 Week Low
  • ₹1,361
  • 52 Week High
  • ₹3,358
  • Open Price₹2,482
  • Previous Close₹2,503
  • Volume97,051

Investment Returns

  • Over 1 Month -8.54%
  • Over 3 Month + 8.74%
  • Over 6 Month + 26.05%
  • Over 1 Year + 75.23%
SIP Lightning

Smart Investing Starts Here Start SIP with Poly Medicure for Steady Growth!

Invest Now

Poly Medicure Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 86.9
  • PEG Ratio
  • 3.3
  • Market Cap Cr
  • 25,613
  • P/B Ratio
  • 17.4
  • Average True Range
  • 116.3
  • EPS
  • 29.1
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -7.81
  • RSI
  • 38.65
  • MFI
  • 29.58

Poly Medicure Financials

Poly Medicure Technicals

EMA & SMA

Current Price
₹2,527.75
+ 24.3 (0.97%)
pointer
  • stock-down_img
  • Bullish Moving Average 5
  • stock-up_img
  • Bearish Moving Average 11
  • 20 Day
  • ₹2,690.02
  • 50 Day
  • ₹2,663.16
  • 100 Day
  • ₹2,506.13
  • 200 Day
  • ₹2,229.46

Resistance and Support

2534.57 Pivot Speed
  • R3 2,699.08
  • R2 2,646.52
  • R1 2,587.13
  • S1 2,475.18
  • S2 2,422.62
  • S3 2,363.23

What's your outlook on Poly Medicure?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Poly Medicure Ltd. is a leading Indian manufacturer of medical devices, specializing in infusion therapy, dialysis, urology, and diagnostics. With 8 global manufacturing facilities, it delivers high-quality healthcare products to patients and healthcare providers worldwide.

Poly Medicure has an operating revenue of Rs. 1,522.46 Cr. on a trailing 12-month basis. An annual revenue growth of 25% is outstanding, Pre-tax margin of 25% is great, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 17% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart and is trading around -6% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 88 which is a GOOD score indicating consistency in earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 20 indicates it belongs to a strong industry group of Medical-Systems/Equip and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Poly Medicure Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-28 Quarterly Results & ESOP
2024-07-22 Quarterly Results
2024-06-29 Others Inter alia, to consider and finalize the terms and condition and approve the modes of fund raising. per share(40%)Interim Dividend
2024-05-17 Audited Results & Final Dividend
2024-03-08 Others Inter alia, to consider a) Business Plan for Financial Year 2024-25. b) To consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s). per share(40%)Interim Dividend

Poly Medicure F&O

Poly Medicure Shareholding Pattern

62.56%
7.35%
3.06%
11.88%
10.13%
5.02%

About Poly Medicure

  • NSE Symbol
  • POLYMED
  • BSE Symbol
  • 531768
  • Managing Director
  • Mr. Himanshu Baid
  • ISIN
  • INE205C01021

Similar Stocks to Poly Medicure

Poly Medicure FAQs

Poly Medicure share price is ₹2,527 As on 28 December, 2024 | 00:25

The Market Cap of Poly Medicure is ₹25612.6 Cr As on 28 December, 2024 | 00:25

The P/E ratio of Poly Medicure is 86.9 As on 28 December, 2024 | 00:25

The PB ratio of Poly Medicure is 17.4 As on 28 December, 2024 | 00:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23